Upcoming verified earnings release
MoonLake Immunotherapeutics Q4 2026 Earnings Preview
Direct answer
MoonLake Immunotherapeutics is scheduled to report Q4 2026 earnings on February 22, 2027.
Before the US market opens. The available EPS estimate is -0.8345.
This page will keep the same address and add the reported result when the verified source provides it.
Verified earnings source
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- February 22, 2027
- Reported timing
- Before the US market opens
- EPS estimate
- -0.8345
- Reported EPS
- Not provided
Explore related company data
Read the frequently asked questions.
When is MoonLake Immunotherapeutics scheduled to report Q4 2026 earnings?
MoonLake Immunotherapeutics is scheduled to report on February 22, 2027. The reported timing is before the us market opens.
What is the available EPS estimate for MoonLake Immunotherapeutics?
The verified record provides an EPS estimate of -0.8345.
Has MoonLake Immunotherapeutics reported the Q4 2026 result?
A reported result has not yet been verified. This same page will show the result after verification.
Which source supports this MoonLake Immunotherapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.